Nuvectis Pharma's total assets for Q4 2025 were $31.71M, a decrease of -10.90% from the previous quarter. NVCT total liabilities were $13.30M for the fiscal quarter, a 14.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.